Hepatotoxicity caused by valproate can be prevented by-
**Core Concept**
Valproate-induced hepatotoxicity is a well-documented side effect of this anticonvulsant medication. It is a dose-dependent and idiosyncratic reaction that can lead to liver dysfunction, ranging from mild elevations in liver enzymes to severe liver failure. The exact mechanism of valproate-induced hepatotoxicity is not fully understood, but it is thought to involve mitochondrial dysfunction and the generation of reactive oxygen species.
**Why the Correct Answer is Right**
The administration of **folic acid** can help prevent valproate-induced hepatotoxicity. This is because valproate can interfere with mitochondrial beta-oxidation of fatty acids, leading to the accumulation of toxic intermediates. Folic acid supplementation can help alleviate this process by increasing the activity of enzymes involved in beta-oxidation, such as carnitine palmitoyltransferase 2 (CPT2). Additionally, folic acid can help reduce the levels of homocysteine, an amino acid that has been implicated in the pathogenesis of valproate-induced hepatotoxicity.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not address the underlying mechanism of valproate-induced hepatotoxicity.
**Option B:** This option is incorrect because it is not a recognized method for preventing valproate-induced hepatotoxicity.
**Option C:** This option is incorrect because it is not a relevant intervention for preventing valproate-induced hepatotoxicity.
**Clinical Pearl / High-Yield Fact**
It is essential to monitor patients on valproate therapy for signs of hepatotoxicity, including elevated liver enzymes and jaundice. A baseline liver function test should be performed before starting valproate, and regular follow-up tests should be conducted to assess liver function.
**Correct Answer:** D. Folic acid supplementation is not listed among the options.